🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carmen A. Paez

Fred Hutch Cancer Center

ORCID: 0000-0001-8640-6623
Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial”.

Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00140-6
N/A
1.1DataRank · unranked
33 citations

Sharon Mannheimer, Carmen A. Paez, Chenchen Yu, Theresa Gamble, Deborah Theodore +22 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

PLoS Medicine(2024)10.1371/journal.pmed.1004329
N/A
0.438DataRank · unranked
16 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +29 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434
N/A
0.395DataRank · unranked
7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9
N/A
0.381DataRank · unranked
11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

The Lancet HIV(2025)10.1016/s2352-3018(25)00012-8
N/A
0.292DataRank · unranked
6 citations

Carmen A. Paez, Chenchen Yu, Shelly Karuna, Theresa Gamble, Maurine D. Miner +32 more

Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa

Nature Communications(2024)10.1038/s41467-024-54580-9
N/A
0.279DataRank · unranked
5 citations

Rena D. Astronomo, Yunda Huang, Sandeep Narpala, Madhu Prabhakaran, Philipp Mann +16 more

A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)

medRxiv(2024)10.1101/2024.01.10.23299799
N/A
0.208DataRank · unranked
3 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +28 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

UNC Libraries(2024)10.17615/jk04-ea73
N/A
0DataRank · unranked
0 citations

Carlos del Rı́o, Adrian B. McDermott, Estelle Piwowar‐Manning, Timothy Skalland, Margaret E. Ackerman +29 more

HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae558
N/A
0DataRank · unranked
0 citations

L. W. Preston Church, Colleen F. Kelley, Samuel T. Robinson, Yiwen Lu, Briana D. Furch +13 more